St Jude Medical Management
St Jude employs about 18 K people. The company is managed by 39 executives with a total tenure of roughly 441 years, averaging almost 11.0 years of service per executive, having 461.54 employees per reported executive. Summary of St Jude's management performance can provide insight into the company performance.
| Michael Rousseau CEO CEO and President COO and Director |
| Sarah Bates Chairman Non-Executive Chairman of the Board |
STJ |
St Jude Management Team Effectiveness
St Jude's management efficiency ratios could be used to measure how well St Jude manages its routine affairs as well as how well it operates its assets and liabilities.St Jude Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific St Jude insiders, such as employees or executives, is commonly permitted as long as it does not rely on St Jude's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, St Jude insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Donald Zurbay over a year ago Exercise or conversion by Donald Zurbay of 1385 shares of St Jude subject to Rule 16b-3 |
St Jude Notable Stakeholders
A St Jude stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as St Jude often face trade-offs trying to please all of them. St Jude's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting St Jude's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Rousseau | CEO and President COO and Director | Profile | |
| Sarah Bates | Non-Executive Chairman of the Board | Profile | |
| Daniel Starks | Executive Chairman | Profile | |
| Denis Gestin | President of International Division | Profile | |
| Jeffrey Dallager | Vice President Corporate Controller | Profile | |
| Joel Becker | President - Americas Division | Profile | |
| Eric Fain | Group President - St. Jude Medical | Profile | |
| Rachel Ellingson | Vice President - Corporate Relations | Profile | |
| Mark Carlson | Vice President - Global Clinical Affairs, Chief Medical Officer | Profile | |
| Paul Bae | Chief Marketing Officer, Vice President - Global Human Resources | Profile | |
| Scott Thome | Vice President - Global Operations and Supply Chain | Profile | |
| Jeff Fecho | Vice President - Global Quality | Profile | |
| Jason Zellers | Vice President General Counsel, Corporate Secretary | Profile | |
| Craig Gentle | CFO | Profile | |
| Donald Zurbay | CFO and VP of Fin. | Profile | |
| John Heinmiller | Executive VP | Profile | |
| Baroness Wheatcroft | Non-Executive Independent Director | Profile | |
| Tony Dunk | Director - Investor Relations | Profile | |
| Stephan Widensohler | Independent Director | Profile | |
| Wendy Yarno | Independent Director | Profile | |
| Iain Cornish | Senior Independent Non-Executive Director | Profile | |
| Richard Devenuti | Independent Director | Profile | |
| Stuart Essig | Independent Director | Profile | |
| Andrew Croft | CFO, Executive Director | Profile | |
| Barbara Hill | Independent Director | Profile | |
| David Bellamy | Chief Executive, Executive Director | Profile | |
| Roger Yates | Independent Non-Executive Director | Profile | |
| John Brown | Independent Presiding Director | Profile | |
| Michael Rocca | Independent Director | Profile | |
| Simon Jeffreys | Independent Non-Executive Director | Profile | |
| J Weigelt | Director - Investor Relations | Profile | |
| David Dvorak | Director | Profile | |
| Robert Gardner | Director of Investment Management | Profile | |
| Stefan Widensohler | Independent Director | Profile | |
| Mark Murphy | CIO and VP of Information Technology | Profile | |
| David Lamb | Managing Director, Executive Director | Profile | |
| Ian Gascoigne | Managing Director, Executive Director | Profile | |
| Lisa Andrade | Chief Marketing Officer | Profile | |
| Elizabeth Kelly | Company Secretary | Profile |
St Jude Workforce Analysis
Traditionally, organizations such as St Jude use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare St Jude within its industry.St Jude Manpower Efficiency
Return on St Jude Manpower
| Revenue Per Employee | 307.8K | |
| Revenue Per Executive | 142.1M | |
| Net Income Per Employee | 48.9K | |
| Net Income Per Executive | 22.6M | |
| Working Capital Per Employee | 34.2K | |
| Working Capital Per Executive | 15.8M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in STJ Stock
If you are still planning to invest in St Jude Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the St Jude's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |